Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity RatioFCF MarginGross MarginInventory AverageInvested CapitalMarket CapitalizationNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on Sales

Burning Rock Biotech (BNR) FCF Margin: 2019-2025

Historic FCF Margin for Burning Rock Biotech (BNR) over the last 6 years, with Sep 2025 value amounting to -1.03%.

  • Burning Rock Biotech's FCF Margin fell 875.00% to -1.03% in Q3 2025 from the same period last year, while for Sep 2025 it was -46.03%, marking a year-over-year decrease of 4767.00%. This contributed to the annual value of -18.94% for FY2024, which is 3016.00% up from last year.
  • Per Burning Rock Biotech's latest filing, its FCF Margin stood at -1.03% for Q3 2025, which was up 96.00% from -25.78% recorded in Q2 2025.
  • In the past 5 years, Burning Rock Biotech's FCF Margin ranged from a high of 17.27% in Q4 2024 and a low of -187.95% during Q3 2023.
  • Moreover, its 3-year median value for FCF Margin was -4.15% (2024), whereas its average is -29.94%.
  • Per our database at Business Quant, Burning Rock Biotech's FCF Margin slumped by 14,970bps in 2021 and then skyrocketed by 19,567bps in 2024.
  • Burning Rock Biotech's FCF Margin (Quarterly) stood at -74.25% in 2021, then surged by 7,705bps to 2.81% in 2022, then plummeted by 214bps to 0.66% in 2023, then soared by 1,661bps to 17.27% in 2024, then crashed by 875bps to -1.03% in 2025.
  • Its FCF Margin was -1.03% in Q3 2025, compared to -25.78% in Q2 2025 and -17.68% in Q1 2025.